eBioscience

San Diego, United States Founded: 1999 • Age: 27 yrs Acquired By Affymetrix
Immunology and oncology flow cytometry reagents are supplied.

About eBioscience

eBioscience is a company based in San Diego (United States) founded in 1999 was acquired by Affymetrix in November 2011. eBioscience offers products and services including Antibodies, ELISA Kits, and Flow Cytometry Tools. eBioscience operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.

Key Metrics

Products & Services of eBioscience

eBioscience offers a comprehensive portfolio of products and services, including Antibodies, ELISA Kits, and Flow Cytometry Tools.

Antibodies
Research Reagents

High-quality primary and secondary antibodies for immunology and flow cytometry research

ELISA Kits
Immunoassays

Kits for reliable protein quantitation in life science applications

Flow Cytometry Tools
Analysis Instruments

Reagents and beads for multicolor flow cytometry and cell separation

Funding Insights of eBioscience

  • Total Rounds 1
  • Last Round Debt – Venture β€” $55M
  • First Round $55M

    (Feb 2011)

  • Investors Count 1

All 1 funding rounds of eBioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2011$55MDebt – Venture––
Valuation history

2 investors in total: 2 institutional.

Investors in eBioscience

eBioscience has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Affymetrix and GE Capital Canada.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Multiple sectors are invested in by this private equity firm.
–gecapital.ca-
Provider of technologies for multiplex and simultaneous analysis of biological systems at the cell, protein, and gene level
1991affymetrix.comSanta Clara, United States
Premium access

Investor details for eBioscience

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of eBioscience

1281 people are tracked at eBioscience (504 in leadership, 18 in board & advisors, 759 in team).

NameRoleGroup
Mike Shafer
SVP & President, Pharma ServicesLeadership
Nader Riad
Director, Advanced EngineeringLeadership
Rachelle Sepich
Senoir HR DirectorLeadership
Benjamin Chong
Senior Director HRLeadership
Tony Farero
Director HR, Global QualityLeadership
David Reirden
VP, HR Productivity & OperationsLeadership
Francis Baker
Senior Director, HR PMO & LRLeadership
Praveen Chauhan
Head Of Information TechnologyLeadership
James Niblock
Director, Managed Access ProgramsLeadership
Angela Thomas
Senior Director Growth & StrategyLeadership
Juan Semanate
Sr. Director - OperationsLeadership
Lori Petersen
Senior HR DirectorLeadership
Jessika Fabiano
Director, Early Talent ProgramsLeadership
Stewart Han
Director, Marketing | Transplant DiagnosticsLeadership
Sjoerd van Den Boom
Director Mechanical Sub-assemblies - Global Procurement Bij Thermo Fisher ScientificLeadership
Aaron Basey
Sr. Director Digital Product ManagementLeadership
Alexander Makarov
Director Global ResearchLeadership
Susanne Moyer
Vice President & General ManagerLeadership
Jackie Reisner
Director, Biostatistics And ProgrammingLeadership
Jon Hardy
Vice President Of Business Development, Biotech SolutionsLeadership

1261 more people are available in the full profile.

Premium access

Complete people profiles for eBioscience

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of eBioscience

3 dated milestones of eBioscience across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded eBioscience is founded.
  2. Funding First funding round of $55.0M.
  3. Exit Acquired by Affymetrix.

Competitors of eBioscience

eBioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
genscript.com2002Piscataway, United States$15M5,260
Reagents and instruments are provided for life sciences research.
sinobiological.com2007Beijing, China$29.41M–
Reagents and kits are provided for clinical research applications.
epitomics.com2001Burlingame, United States$16.21M–
Monoclonal antibody technology and products are developed by Epitomics.
ybiologics.com2007Daejeon, South Korea$42.1M–
Developer of antibodies for the treatment of multiple diseases
mabtech.com1986Nacka, Sweden––
Antibodies and immunoassay kits are developed for research applications.
opmbiosciences.com2013Pudong, China$14.42M–
Antibody and vaccine culture media products are developed.
itb-med.com2016Stockholm, Sweden$87M–
Monoclonal antibodies are developed to prevent transplant rejections.
abrevbio.com2018Nanjing, China$90M–
Antibody-drug development platforms are provided for life sciences research.
vectorlabs.com1976Burlingame, United States––
Labeling and detection reagents immunohistochemistry studies and other life science research applications
allelebiotech.com1999San Diego, United States$18M–
Nano-antibodies, iPSCs, fluorescent proteins, and RNAi are developed.
Premium access

Detailed competitors of eBioscience

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of eBioscience

Websites that share an audience with eBioscience (ebioscience.com).

Similar websites

Websites whose visitors overlap most with eBioscience. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
biolegend.com
100%
229.6K#142,656View details
bdbiosciences.com
99%
331.8K#154,504View details
abdserotec.com
97%
––View details
ancell.com
ancell.com
95%
–#5,981,503–
rndsystems.com
86%
349K#159,292View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 30 similar websites and full traffic analytics for eBioscience

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 30 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Ebioscience

Premium access

Complete news archive for eBioscience

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to eBioscience

10 companies that operate in the same segment as eBioscience (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about eBioscience

eBioscience was founded in 1999 and raised its 1st funding round 12 years after it was founded.

eBioscience is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

eBioscience was founded in 1999 and is headquartered in San Diego, United States. Reagents for immunology and oncology flow cytometry are provided within the biotechnology sector. Antibodies, fluorochromes, and related products for cell biology, stem cell biology, and diagnostics are included in the portfolio. Operations focus on supporting research and diagnostic applications. Development of 800 new products for multicolor flow cytometry has been reported.

eBioscience's top competitors include Sino Biological, GenScript and Y-Biologics.

eBioscience offers Antibodies, ELISA Kits, and Flow Cytometry Tools.

eBioscience has 2 investors. Key investors include Affymetrix, and GE Capital Canada.

Yes. eBioscience was acquired by Affymetrix in November 2011.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available